Joint Formulary & PAD

Fluticasone with umeclidinium and vilanterol (Trelegy Ellipta) - Chronic Obstructive Pulmonary Disease (COPD)

You are here : Home > Formulary Search > Fluticasone with umeclidinium and vilanterol (Trelegy Ellipta) - Chronic Obstructive Pulmonary Disease (COPD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Inhaler (dry powder)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
SPC
Restrictions / Comments :

Documentation

Guidelines (Local)
COPD Primary Care Medicines Management Guidelines - updated Jun 23
Guidelines (National)
NICE NG115 COPD diagnosis and management

PAD Profile

ChemicalSubstance :
Fluticasone with umeclidinium and vilanterol (Trelegy Ellipta)
Indication :
Chronic Obstructive Pulmonary Disease (COPD)
Group Name :
Triple therapy
Keywords :
LABA beta agonist, long acting, ICS, antimuscarinic, triple therapy
Brand Names Include :
Trelegy Ellipta
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Chronic Obstructive Pulmonary Disease (COPD)
Supporting Documents :
2

Committee Recommendations (1)

07 Jun 23 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The locally preferred triple-therapy devices for COPD are as follows:

Low carbon:

  • Trimbow NEXThaler (dry powder)
  • Trelegy Ellipta (dry powder)

Alternative devices:

  • Trimbow (pMDI). To be used with a spacer.

Triple therapy combination inhalers are recommended as a treatment option in COPD, where clinically appropriate, in line with NICE guidance (NG115 –updated July 2019) and GOLD guidelines.

See local COPD guidelines for further details

Other Indications

Below are listed other indications that Fluticasone with umeclidinium and vilanterol (Trelegy Ellipta) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).